Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
139M
-
Shares change
-
-2.27M
-
Total reported value, excl. options
-
$2.35B
-
Value change
-
-$21.1M
-
Put/Call ratio
-
0.79
-
Number of buys
-
96
-
Number of sells
-
-70
-
Price
-
$16.85
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q4 2015
211 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2015.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 139M shares
.
Largest 10 shareholders include OppenheimerFunds, Inc. (26M shares), PRIMECAP MANAGEMENT CO/CA/ (19.8M shares), VANGUARD GROUP INC (10.5M shares), BlackRock Fund Advisors (9.86M shares), FIRST TRUST ADVISORS LP (9.6M shares), Invesco Ltd. (4.38M shares), FEDERATED INVESTORS INC /PA/ (3.88M shares), Camber Capital Management LLC (3.5M shares), STATE STREET CORP (3.33M shares), and BlackRock Institutional Trust Company, N.A. (3.3M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.